2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgerySigrun Halvorsen, Volkmar Falk, Tatjana Potpara et al.|European Heart Journal|2022Cited by 1.1k
Vutrisiran in Patients with Transthyretin Amyloidosis with CardiomyopathyMarianna Fontana, Mathew S. Maurer, John L. Berk et al.|New England Journal of Medicine|2024Cited by 356
The Clinical Significance of Interleukin-6 in Heart Failure: Results from the BIOSTAT-CHF StudyGeorge Markousis‐Mavrogenis, Peter van der Meer, Jasper Tromp et al.|European Journal of Heart Failure|2019Cited by 281
Cardiovascular Toxicities of Immune Therapies for Cancer – A Scientific Statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-OncologyCarlo G. Tocchetti, Alexander R. Lyon, Teresa López‐Fernández et al.|European Journal of Heart Failure|2024Cited by 64
The Role of Cathepsin D in the Pathophysiology of Heart Failure and its Potentially Beneficial Properties: A Translational ApproachMartijn F. Hoes, Peter van der Meer|European Journal of Heart Failure|2019Cited by 39